Wednesday, August 25, 2010 2:49:57 PM
Now for educational purposes I will explain how this works:
The rep will engage the physician and explain the benefits vs the current pain relievers, which is a huge issue right now and the physicians are going to be all ears, because many of them are under scrutiny for over prescribing pain meds that are addictive and down right dangerous. Every physician out there is also well aware of the situation regarding acetomenophen and other OTC pain meds that are more harmful than good for their patients. This is a huge hot button and when given a logical alternative they will bypass the system to suit their patient needs without blinking an eye.
I have been a pharmaceutical rep for P&G for many years and I DO understand this business and this is why I am so enthused what NPHC is bringing to market. Nyloxin RX will be great alternatives for physicians to use for their patients and I believe Henry Schein will also carry Nyloxin and Nyloxin ES, but I am not completely sure of that yet, but if they do it would absolutely no problem to recommend the patient to go to the pharmacy and pick it up.
The issue is about who knows what is going on and does there due diligence correctly!
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM